St. Petersburg-based Claro Scientific has won the highly regarded ‘EARLY/Stage Shootout’ competition at Southeast BIO’s 13th Annual Investor Forum held in Durham, North Carolina. Claro was selected from among 60 early-stage medical device, drug and biotechnology companies. The company is advancing SpectraWave, a low cost, easy to use point-of-care diagnostic system licensed from the University of South Florida in Tampa, FL.